Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 May 2025 | Story Precious Shamase | Photo Supplied
Dr Regret Sunge
Dr Regret Sunge – the newly rated NRF Y2 academic.

The University of the Free State (UFS) is proud to announce that Dr Regret Sunge, Lecturer in the Department of Economics and Finance within the Faculty of Economic and Management Sciences, has been awarded a prestigious Y2 rating by the National Research Foundation (NRF). This significant achievement highlights Dr Sunge's exceptional potential as a rising leader in the field of economics and finance.

The NRF Y2-rating is bestowed upon young researchers, typically under the age of 40 and within five years of obtaining their PhD, who have demonstrated considerable potential to establish themselves as leaders in their area of expertise. Dr Sunge's inclusion among the 3,8% of newly rated researchers in South Africa highlights the quality and impact of his work.

Dr Sunge expressed his excitement, stating, "I am thrilled to have received the NRF Y2-rating for the period 1 January 2025 to 31 December 2030. Receiving such recognition through this meticulous process in the field of Economics and Finance – which has a share of only 4,9% of total rated researchers – is even more amazing." He further emphasised the rigorous nature of the NRF rating process, and the insightful feedback received.

 

Factors contributing to this recognition

Dr Sunge attributes his success to a combination of personal dedication, collaborative efforts, and institutional support. His PhD thesis provided a strong foundation, with three of the five reviewed papers originating from this work. Subsequent research collaborations with international peers fostered during his PhD journey further enriched his research by integrating the critical fields of agricultural production and environmental sustainability. The growing number of citations his work has received speaks to its increasing relevance and impact.

The academic also acknowledged the significant influence of key individuals on his research journey, including his PhD supervisor, Prof Nicholas NgepahDr Delphin Kamanda Espoir – a research partner, and his postdoctoral host, Dr Calvin Mudzingiri.

Beyond academic research, Dr Sunge's engagement in research consultation with regional and international organisations has played a vital role. In 2022, he formed a team within the United Nations Young Economists Network (UN-YEN) to study Africa's macroeconomic growth. Additionally, he contributed as a research assistant to the Organisation of Economic Cooperation and Development (OECD) and the African Union Commission (AUC) for their annual Africa Development Dynamics (AfDD) publication.

Dr Sunge also highlighted the crucial institutional support he received from the University of the Free State, specifically the Faculty of Economic and Management Sciences (EMS) on the Qwaqwa Campus, where he was a postdoctoral research fellow at the time of application.

 

Impact of the NRF rating on research standing

The Y2 rating is already proving to be a catalyst for Dr Sunge's research endeavours. "It’s a motivator, I am more confident, and it has greatly enhanced my CV," he noted. He anticipates that this recognition will unlock opportunities for further collaborations and access to competitive research grants and funding programmes, both nationally and internationally.

Furthermore, Dr Sunge's achievement while based on the Qwaqwa Campus enhances the University of the Free State's reputation for supporting young researchers and fostering excellence across all its campuses. His rating serves as a significant source of inspiration for his colleagues on the Qwaqwa Campus, particularly within EMS, where NRF-rated researchers are still few. Dr Sunge hopes that his success will encourage colleagues in the faculty to pursue similar achievements through commitment, dedication, and collaboration.

 

Research focus and its importance

Dr Sunge's research primarily focuses on the intersection of agricultural production and environmental sustainability. His work addresses the critical challenge of ensuring food security amid the growing impact of climate change in a sustainable manner. Recognising the dual challenge of increasing agricultural output to combat food insecurity while mitigating climate change, his research aims to inform environmentally sustainable agrifood systems in South Africa and beyond.

Specifically, his research holds local relevance for Phuthaditjhaba, where livestock agriculture is a significant part of the local economy, with the potential to contribute to more sustainable livelihoods. Utilising a range of econometric methodologies, his research approach is adaptable to various fields of study, facilitating collaboration with researchers from diverse backgrounds.

Acknowledging the dynamic nature of research in economics, particularly in econometrics and data analysis, Dr Sunge emphasises the importance of continuous learning through conferences and workshops. He aims to further develop his econometric and critical thinking skills, as well as sharpen his writing abilities, to elevate his research to new heights.

 

Future research trajectory

Looking ahead, Dr Sunge envisions a research trajectory that combines academic rigour with impactful societal engagement. This involves identifying research problems, providing in-depth academic analysis, and developing solutions that directly benefit communities. His future includes initiating research-based interventions and conducting impact assessments. Achieving this vision necessitates securing research grants, supervising postgraduate students, and actively engaging in community initiatives.

 Over the next five years, Dr Sunge aims to transition from a Y2 to a C-rated researcher, a goal that requires careful planning to balance his research and teaching responsibilities. While committed to advancing his research, Dr Sunge remains passionate about teaching and ensuring that his research activities enhance, rather than detract from, his classroom engagement.

 Dr Sunge’s achievement of the NRF Y2-rating is a significant milestone, both for his personal career and for the University of the Free State. His dedication, collaborative spirit, and impactful research focus serve as an inspiration to colleagues and aspiring economists alike. As Dr Sunge eloquently stated, "My word to aspiring economists, especially from marginalised circumstances, is that with the right mindset, commitment and dedication, we can be counted."

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept